Get started
XORTX Therapeutics Inc.XORTX Therapeutics Inc.XORTX Therapeutics Inc.

XORTX Therapeutics Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Technicals Forecast

XRTX chart

Key stats

Market capitalization
‪6.69 M‬USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−1.11USD
Net income
‪−2.20 M‬USD
Revenue
—
Shares float
‪1.79 M‬
Beta (1Y)
2.41

About XORTX Therapeutics Inc.

Sector
Health Technology
CEO
Allen Warren Davidoff
Headquarters
Calgary
Website
xortx.com
Employees (FY)
17
Founded
2011
ISIN
CA98420Q3061
FIGI
BBG00KVK0YG4
XORTX Therapeutics, Inc. is a biopharmaceutical company. The firm engages in development and commercialization of innovative therapies. It focuses on drug therapies for rare orphan disease indications such as polycystic kidney disease, and the treatment of health consequences caused by chronic high serum uric acid or hyperuricemia, including Type 2 Diabetic Nephropathy, cardiovascular disease, and diabetes. The company was founded by Allen Davidoff on May 31, 2011 and is headquartered in Calgary, Canada.

Financials

Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

News

Keep reading

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating

An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Stock brokers

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of XRTX is 3.22 USD — it has decreased by 4.17% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange XORTX Therapeutics Inc. stocks are traded under the ticker XRTX.
XORTX Therapeutics Inc. is going to release the next earnings report on May 29, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for XORTX Therapeutics Inc. has a max estimate of 13.99 USD and a min estimate of 10.24 USD.
XRTX earnings for the last quarter are −0.67 USD whereas the estimation was −2.02 USD which accounts for 66.62% surprise. Estimated earnings for the next quarter are −0.69 USD. See more details about XORTX Therapeutics Inc. earnings.
Yes, you can track XORTX Therapeutics Inc. financials in yearly and quarterly reports right on TradingView.
Like other stocks, XRTX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade XORTX Therapeutics Inc. stock right from TradingView charts — choose your broker and connect to your account.
XRTX reached its all-time high on Nov 4, 2021 with the price of 53.02 USD, and its all-time low was 1.98 USD and was reached on Dec 27, 2023.
See other stocks reaching their highest and lowest prices.
As of Apr 16, 2024, the company has 17.00 employees. See our rating of the largest employees — is XORTX Therapeutics Inc. on this list?